| Literature DB >> 27984730 |
April Pawluk1, Nadia Amrani2, Yan Zhang2, Bianca Garcia3, Yurima Hidalgo-Reyes3, Jooyoung Lee2, Alireza Edraki2, Megha Shah1, Erik J Sontheimer4, Karen L Maxwell5, Alan R Davidson6.
Abstract
CRISPR-Cas9 technology would be enhanced by the ability to inhibit Cas9 function spatially, temporally, or conditionally. Previously, we discovered small proteins encoded by bacteriophages that inhibit the CRISPR-Cas systems of their host bacteria. These "anti-CRISPRs" were specific to type I CRISPR-Cas systems that do not employ the Cas9 protein. We posited that nature would also yield Cas9 inhibitors in response to the evolutionary arms race between bacteriophages and their hosts. Here, we report the discovery of three distinct families of anti-CRISPRs that specifically inhibit the CRISPR-Cas9 system of Neisseria meningitidis. We show that these proteins bind directly to N. meningitidis Cas9 (NmeCas9) and can be used as potent inhibitors of genome editing by this system in human cells. These anti-CRISPR proteins now enable "off-switches" for CRISPR-Cas9 activity and provide a genetically encodable means to inhibit CRISPR-Cas9 genome editing in eukaryotes. VIDEO ABSTRACT.Entities:
Keywords: CRISPR-Cas; Cas9; Neisseria meningitidis; anti-CRISPR; genome editing; phage
Mesh:
Substances:
Year: 2016 PMID: 27984730 PMCID: PMC5757841 DOI: 10.1016/j.cell.2016.11.017
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582